ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $54,037 | -23.4% | 1,991,002 | -13.2% | 0.01% | -20.0% |
| Q2 2023 | $70,532 | -20.9% | 2,294,416 | -7.3% | 0.01% | -23.1% |
| Q1 2023 | $89,210 | -9.9% | 2,475,947 | -1.1% | 0.01% | -18.8% |
| Q4 2022 | $98,979 | -99.9% | 2,504,532 | +6.9% | 0.02% | +6.7% |
| Q3 2022 | $94,135,000 | -4.8% | 2,342,810 | -0.4% | 0.02% | +25.0% |
| Q2 2022 | $98,901,000 | +12.3% | 2,352,542 | +4.0% | 0.01% | +33.3% |
| Q1 2022 | $88,096,000 | -2.9% | 2,261,199 | -0.7% | 0.01% | +12.5% |
| Q4 2021 | $90,761,000 | +14.3% | 2,277,559 | +3.7% | 0.01% | +14.3% |
| Q3 2021 | $79,390,000 | -12.0% | 2,196,736 | -0.1% | 0.01% | -12.5% |
| Q2 2021 | $90,172,000 | -12.2% | 2,199,853 | -6.6% | 0.01% | -20.0% |
| Q1 2021 | $102,691,000 | -36.1% | 2,354,218 | -26.6% | 0.01% | -37.5% |
| Q4 2020 | $160,618,000 | -53.6% | 3,209,155 | -61.0% | 0.02% | -60.0% |
| Q3 2020 | $346,280,000 | -11.1% | 8,231,050 | +2.6% | 0.04% | -18.4% |
| Q2 2020 | $389,491,000 | – | 8,022,471 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |